


Fractional exhaled nitric oxide (FENO) monitoring for airway inflammation, asthma and COPD
Measuring Feno with NObreath allows consistent, non-invasive measurement of expired breath nitric oxide (NO).
This can be used as a marker for airway inflammation such as asthma, and aid on-going monitoring of treatment.1 Feno is a non-invasive, valid marker of airway inflammation, making analysis and monitoring safe, quick and easy.
The relation between elevated levels of Feno and airway inflammation in asthma sufferers is well established.2 NObreath provides affordable Feno monitoring that is accessible to many healthcare professionals.
The hand-held device enables respiratory specialists, doctors and asthma specialists to largely comply with ATS and ERS guidelines3 when testing Feno levels in patients. Adults and children can be easily tested, correctly assessed and promptly prescribed the correct treatment regime thus saving time and further reducing costs
NObreath uses the NObreathFloTM sample conditioning and entrapment system; a re-usable device that ensures the consistency of each test. Single-use disposable mouthpieces attach to the NObreathFloTM for cost-effective infection control.

Ascencia Limited
PO Box 2503
Bowral, NSW,
Australia, 2576
T +61 (0) 2 4861 6169
F +61 (0) 2 4861 6169
E info@ascencia.com.au
Homepage | About | Contact | Our Products | Our Services | Site Terms
Product Categories: Product Directory
Pulmonary Function Testing | Exhaled Nitric Oxide | Rehabilitation | Sleep Medicine | Metabolic and Stress Testing
Performance Training and Sports Medicine | Breath Condensate | Finance | PC Solutions